Jioan Medical Stock Surges 20% Over 3 Days; Clarifies AI in Diabetes Care Not Separately Charged

According to an official announcement on May 25, Jioan Medical's stock price rose by more than 20% cumulatively over three consecutive trading days (May 21-25), triggering an abnormal trading fluctuation alert. The company clarified that its diabetes care service and "AIoT Diabetes Family Medical Assistant" project incorporate AI tools but do not charge separately for AI functionality and do not constitute a standalone business segment. In 2025, this business generated approximately 122 million yuan in revenue, representing 8.93% of total operating revenue and having minimal material impact on overall company performance.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments